Evidence-based lists covering every corner of perimenopause and menopause — because you deserve clear answers, not a wall of text.
63 lists and countingClot risk, liver load, blood pressure, bioavailability — 11 key ways transdermal and oral HRT differ and why delivery route matters for your safety.
Ospemifene treats vaginal dryness without estrogen. Here's what it is, who it's for, and why almost no one has heard of it.
Fezolinetant blocks the NK3 receptor to reduce hot flashes without hormones. Here's what the efficacy data, liver monitoring, and cost picture actually look like.
Outdated HRT fears and dismissed symptoms are still circulating in clinics. Here's what the evidence actually says — so women can push back.
Migraine with aura complicates HRT decisions in ways most women aren't told. Here's what the evidence actually shows about route, type, and dose.
Micronized progesterone as a standalone therapy can ease sleep disruption, anxiety, and heavy periods in early perimenopause — before estrogen is ever needed.
Migraine with aura doesn't automatically rule out HRT. Here's what the evidence actually says about route, dose, and real stroke risk.
Testosterone for menopausal women is gaining real evidence. Here are 9 honest, research-grounded facts to help you decide if it's worth exploring.
LDN is a little-known option for perimenopause pain, autoimmune flares, and mood swings. Here's what the evidence actually says.
GSM causes dryness, pain, and urinary symptoms — but most women only hear about vaginal estrogen. Here are 11 evidence-based options worth knowing.
Patches vs gels for HRT: adhesion, sweating, dose equivalence, skin rotation and absorption explained so women can make genuinely informed choices.
Testosterone does far more than boost libido in menopausal women. Here's what the evidence says about energy, brain, bones, and muscle.
Ospemifene is an oral pill approved for vaginal GSM symptoms. Here is what the evidence actually says and who it genuinely helps.
Outdated HRT beliefs still circulating in GP surgeries — and the current evidence that corrects every one of them.
Not every woman can or wants HRT. These 11 non-hormonal options have real clinical evidence behind them — here's what they treat and how strong that evidence is.
The window of opportunity for HRT may protect your heart and brain — but only if you start in time. Here's what the evidence actually says about timing.
Starting HRT when you take levothyroxine? Estrogen changes how thyroid hormone is carried in the blood — and your dose may need rethinking.
SERMs offer real menopause symptom relief for women who can't take HRT. Here's what the evidence says — and why most women never hear about them.
HRT protects cartilage, tendons, muscles and joints — not just bone density. Here are 11 benefits women rarely hear about at the point of prescription.
Ospemifene is an oral SERM proven to treat vaginal dryness and painful sex — but most women in perimenopause have never been offered it. Here's what it actually does.
SERMs offer tissue-specific estrogen activity without systemic estrogen. Here's what women in perimenopause and menopause need to know about how they work.
Ospemifene treats vaginal dryness and painful sex without estrogen. Here's what women need to know about how it works, who it's for, and what to expect.
HRT does more than reduce wrinkles. Here's what the research actually says about collagen, wound healing, skin barrier, and sebaceous gland function.
The timing hypothesis explains why starting HRT early in menopause may protect your heart and brain — and why later initiation carries different risks.